PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Read More…
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Phone561-526-4444
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$283.42 million
Profitability
Miscellaneous
Employees187
Next Earnings Date10/28/2019 (Estimated)
OptionableOptionable
Petmed Express (NASDAQ:PETS) Frequently Asked Questions
What is Petmed Express' stock symbol?
Petmed Express trades on the NASDAQ under the ticker symbol "PETS."
How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?
Petmed Express announced a quarterly dividend on Monday, July 22nd. Investors of record on Friday, August 2nd will be paid a dividend of $0.27 per share on Friday, August 9th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 6.60%. The ex-dividend date of this dividend is Thursday, August 1st. View Petmed Express' Dividend History.
How were Petmed Express' earnings last quarter?
Petmed Express Inc (NASDAQ:PETS) released its earnings results on Monday, July, 22nd. The company reported $0.26 EPS for the quarter, missing analysts' consensus estimates of $0.42 by $0.16. The business had revenue of $79.99 million for the quarter, compared to analysts' expectations of $85.83 million. Petmed Express had a return on equity of 23.42% and a net margin of 11.05%. The business's revenue for the quarter was down 8.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.62 earnings per share. View Petmed Express' Earnings History.
When is Petmed Express' next earnings date?
What price target have analysts set for PETS?
1 equities research analysts have issued 1-year price targets for Petmed Express' stock. Their forecasts range from $15.00 to $15.00. On average, they anticipate Petmed Express' share price to reach $15.00 in the next twelve months. This suggests that the stock has a possible downside of 8.3%. View Analyst Price Targets for Petmed Express.
What is the consensus analysts' recommendation for Petmed Express?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.
Has Petmed Express been receiving favorable news coverage?
Media stories about PETS stock have been trending positive recently, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Petmed Express earned a daily sentiment score of 2.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the near future. View News Stories for Petmed Express.
Are investors shorting Petmed Express?
Petmed Express saw a decrease in short interest during the month of July. As of July 31st, there was short interest totalling 10,085,600 shares, a decrease of 8.4% from the June 30th total of 11,004,600 shares. Based on an average daily trading volume, of 835,300 shares, the days-to-cover ratio is presently 12.1 days. Approximately 50.8% of the company's shares are short sold. View Petmed Express' Current Options Chain.
Who are some of Petmed Express' key competitors?
What other stocks do shareholders of Petmed Express own?
Who are Petmed Express' key executives?
Petmed Express' management team includes the folowing people:
- Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
- Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
- Ms. Alison Berges, Corp. Sec. & Gen. Counsel
Who are Petmed Express' major shareholders?
Petmed Express' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.27%), Renaissance Technologies LLC (9.49%), Vanguard Group Inc. (6.98%), Morgan Stanley (4.17%), Man Group plc (2.43%) and Bank of New York Mellon Corp (2.26%). Company insiders that own Petmed Express stock include Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.
Which institutional investors are selling Petmed Express stock?
PETS stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Russell Investments Group Ltd., Morgan Stanley, JPMorgan Chase & Co., Uniplan Investment Counsel Inc., Invesco Ltd., SG Americas Securities LLC and Pinebridge Investments L.P.. View Insider Buying and Selling for Petmed Express.
Which institutional investors are buying Petmed Express stock?
PETS stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Man Group plc, Vanguard Group Inc., Inlet Private Wealth LLC, Rothschild Investment Corp IL, Balter Liquid Alternatives LLC, Scout Investments Inc. and BNP Paribas Arbitrage SA. View Insider Buying and Selling for Petmed Express.
How do I buy shares of Petmed Express?
Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Petmed Express' stock price today?
One share of PETS stock can currently be purchased for approximately $16.36.
How big of a company is Petmed Express?
What is Petmed Express' official website?
How can I contact Petmed Express?
Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.
MarketBeat Community Rating for Petmed Express (NASDAQ PETS)
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
